Roche to launch instrument-free SARS-CoV-2 Rapid Antigen Test enabling convenient use for healthcare professionals at different point of care locations. Learn more: https://t.co/WUagCjpg7w #ROG #RHHBY #COVID19 pic.twitter.com/315lHvkljL
— Roche (@Roche) September 1, 2020
We are pleased to announce that our test to simultaneously detect and differentiate #SARSCoV2, #influenza A and/or influenza B viruses has received FDA Emergency Use Authorization. The test is also available in markets accepting the CE mark. https://t.co/rkFKuekdGO $ROG $RHHBY pic.twitter.com/MUo9dGDmtb
— Roche (@Roche) September 4, 2020
Roche and @Regeneron joining forces to fight #covid19 to develop, manufacture & distribute an anti-viral #antibody combination that is being studied for its potential to treat and #prevent infection in those exposed to the virus.#StrongerTogetherhttps://t.co/fs4P14Lqp3 pic.twitter.com/R6qcuZ5yxK
— Roche (@Roche) August 19, 2020
Digital solutions can increasingly capture a variety of #healthdata. The insights gained from that information help personalise care over time. https://t.co/wqpswWZo73 #precisionmedicine pic.twitter.com/t0m1emo34D
— Roche (@Roche) August 17, 2020
Tim M. Jaeger, M.D. is Global Head of Diagnostics Information Solutions at Roche Diagnostics, talks about the future of #healthcare, the power of knowledge and why human interaction will remain indispensable in the age of #digitalisation https://t.co/vZBs8H6pGY #AI pic.twitter.com/GvTC2F3VuX
— Roche (@Roche) August 14, 2020
People have come to embrace virtual care. Learn why #digital tools could also help cancer patients actively manage their disease. https://t.co/Et5WBQRuWO #digitalhealth #oncology pic.twitter.com/x9IGd0ame6
— Roche (@Roche) August 12, 2020
Can the recent boost in healthcare #digitalisation transform the industry? Read more in the Roche-sponsored report by @HarvardBiz Analytics Services. https://t.co/EtZSizNAyM
— Roche (@Roche) August 11, 2020
Roche has been conducting neuroscience research for decades. But we can’t do it alone. In fact, 50% of our medicines come from successful collaborations around the world. Learn more about one of our recent partnerships in #neuroscience: https://t.co/yBn400D1Fe
— Roche (@Roche) August 11, 2020
Making biologics is complicated and time-consuming under the best circumstances. But in the midst of a #pandemic, our Pharma #Technology Operations teams are doing it faster than ever 👉 https://t.co/LsWjHb6vLk #COVID19 #Healthcare #Health #Tech pic.twitter.com/AxnodVeA7M
— Roche (@Roche) August 10, 2020
Peru is among the Latin American countries most affected by #COVID19. To alleviate the local #health system in Peru, Roche partnered with Smart Doctor to provide #telehealth services to the general population 👉 https://t.co/T5EvlafRX4 #Innovation #Technology #Tech #Digital pic.twitter.com/27jQuimZ7X
— Roche (@Roche) August 7, 2020
Patients and healthcare institutions struggle with data overload. Cloud-based clinical decision support #software facilitates cancer case review from anyplace. https://t.co/wqpswWZo73 pic.twitter.com/65ru76tsIf
— Roche (@Roche) August 5, 2020
We are proud to be working with the team from @spark_tx and look forward to our future #innovation journey together. We couldn’t be more thrilled about what’s next #TransformingLives #science https://t.co/DctgocJACT
— Roche (@Roche) July 31, 2020
Treatment decision making doesn’t have to stop because experts cannot meet in person. With virtual tumour boards powered by cloud-based technology #cancer care can continue. https://t.co/YbTbLhr4Ud #personalisedhealthcare pic.twitter.com/AalzXgf7kx
— Roche (@Roche) July 31, 2020
Automating repetitive manual tasks associated in today’s modern molecular diagnostics laboratories improves efficiency and provides consistent and high-quality pre-analytics. https://t.co/ebY1bALuqM #Diagnostics
— Roche (@Roche) July 30, 2020
Widespread, reliable testing can help the world chart a course through the #COVID19 #pandemic and back to normal life. But why is finding a treatment so complex? Read more on why viruses are to hard to treat https://t.co/jX9xGu95E5 #TransformingLives #science #innovation pic.twitter.com/wWO29eQChu
— Roche (@Roche) July 29, 2020
#DYK the first test to monitor hepatitis C viral load in a person's blood was introduced in 1993? This actually changed the approach to #HCV disease management worldwide. #WorldHepatitisDay #diagnostics pic.twitter.com/haNWqbpGuR
— Roche (@Roche) July 29, 2020
With #COVID19 we've broken barriers we never knew existed, leading to accelerated timelines and efficiencies for #research all across our treatment portfolios. Read here about the importance of diversity in clinical trials 👉 https://t.co/4boXhYOZGG #TransformingLives #science pic.twitter.com/INJRUM2mBd
— Roche (@Roche) July 29, 2020
Finding millions who are living with hepatitis is challenging, as many don’t want to get tested because of stigma and lack of knowledge. Learn about Adeline’s experience of living with hepatitis. https://t.co/Sz5t84QdBX #WorldHepatitisDay pic.twitter.com/E8c7c5CRgu
— Roche (@Roche) July 28, 2020
Is it possible to turn an industrial park into a #biodiverse paradise? You’ll “bee” surprised! https://t.co/yxh9zDnpQZ 🐝 #EverGreener #FaceTheChange #sustainability #environment pic.twitter.com/2zkUj3ltFb
— Roche (@Roche) July 11, 2020
We are excited to partner with @reverielabs to further explore the potential of #ArtificialIntelligence to advance drug discovery across Roche's and @Genentech's R&D units.#StrongerTogerher #AI #innovation https://t.co/HDLr6uC1Wm
— Roche (@Roche) July 8, 2020
#DYK conventional #tissue sampling for #cancer diagnosis uses only 0.0005% of a tumour. Vital information that could help determine the best treatment options for each patient might be missing. Learn how our new sampling approach can change that. https://t.co/t4dR10f9BG pic.twitter.com/SA0kLxkber
— Roche (@Roche) July 1, 2020
How do we balance speed with safety? What safety measures can’t be compromised? Hear Ivan Rosas, Professor and Section Chief at Baylor College of Medicine, discussing balancing speed and safety in drug trials during a #pandemic #COVID19 #Science pic.twitter.com/1kt2TYiQjU
— Roche (@Roche) August 15, 2020
What does and doesn't constitute robust evidence, and why does it matter when looking for a cure? Dr Stefan Frings, Global Head of Medical Affairs, Roche Pharma Product Development, shares his view on rigorous evidence 👇🏽 #Science #Research #Innovation #COVID19 pic.twitter.com/VPU09TbN5J
— Roche (@Roche) August 14, 2020
Hear Ivan Rosas, Professor and Section Chief at Baylor College of Medicine, discussing balancing speed and safety in drug trials during a #pandemic #COVID19 #science #innovation pic.twitter.com/ZVRpvWygE4
— Roche (@Roche) July 30, 2020
Chest pain is one of the most common heart attack symptoms, but over 50% of people in the emergency room complaining of chest pain do not have a heart attack. #valueofdiagnostics https://t.co/1eYk5UkZln
— Roche (@Roche) September 1, 2020
New partnership! Expanding in the field of #AI #ArtificialIntelligence https://t.co/i6fe0mMZSz
— Roche (@Roche) August 26, 2020
What does #MedicalValue mean to you? Check this video to see what cardiologist van Wijk thinks. #CarDiaLogue pic.twitter.com/i7kqOK8Rdl
— Roche (@Roche) September 8, 2020
We are pleased to announce the FDA clearance of a new quantitative in vitro molecular test for #bkvirus to support care for #transplant patients. https://t.co/F66Vg2rbTn $ROG $RHHBY #Media pic.twitter.com/NUBNu9u4qR
— Roche (@Roche) September 8, 2020
Antigen and PCR tests enable decision-making whether patients need to be put in quarantine, reducing the risk of further spreading of #SARSCoV2, the virus causing #COVID19 #coronavirus pic.twitter.com/jEzp7xyfry
— Roche (@Roche) September 7, 2020
We are pleased to announce, in partnership with @BlueprintMeds, that our medicine for the treatment of RET fusion-positive #NSCLC has been approved via the FDA’s Accelerated Review programme. Find out more here: https://t.co/9x9xae1Trj $RHHBY $ROG pic.twitter.com/oWyJixFzPM
— Roche (@Roche) September 7, 2020
What is a rigorous or robust scientific trial and why is it so important? Jenny Devenport sheds light on what happens in rigorous, scientific clinical trials, and why not all studies and trials provide the same quality of information https://t.co/3QVKhOM8Fu #COVID19 #Coronavirus pic.twitter.com/XkOLabXdCM
— Roche (@Roche) September 5, 2020
Did you know that over 437,000 people are diagnosed with #leukemia each year? If you have been affected by this, why not share your story this #WorldLeukemiaDay and help others #SpotLeukaemia. Find out more here: https://t.co/e6isatgalv #TransformingLives pic.twitter.com/s7KPADF5AS
— Roche (@Roche) September 4, 2020
We are pleased to announce the FDA approval of an #HIV test to help detect, confirm and differentiate HIV-1 and HIV-2 infections, which is crucial for personalised management of patients living with HIV. https://t.co/tavat4tcos $ROG $RHHBY #Media pic.twitter.com/ZV6GqpK1Um
— Roche (@Roche) September 1, 2020
We are pleased to announce that the U.S. FDA has approved @FoundationATCG's new comprehensive, pan-tumour liquid biopsy test, for patients with advanced #cancer. https://t.co/FCMPlHoRA4 $ROG $RHHBY #media pic.twitter.com/lFZfsUCl1Z
— Roche (@Roche) August 28, 2020
Have you ever asked yourself what is the difference between #molecular and #serology testing? #Diagnostics terms might be indeed sometimes confusing. We can help you to find the right answer! https://t.co/DLxbaVRiE1 pic.twitter.com/jdmnn3LxjB
— Roche (@Roche) August 28, 2020
Rare neurological conditions can create barriers that impact upon a person’s ability to live independently, to move, to remember. At Roche, we continue to focus on research for these challenging conditions. Read more here https://t.co/0M7aJyM1jA pic.twitter.com/jA5YZEs0M5
— Roche (@Roche) August 27, 2020
2020 was for Mirriam Mansour’s to plan her wedding, a work anniversary, health and happiness. Instead, this year brought an unrelenting #pandemic, a #COVID19 diagnosis and a #BeirutExplosion: https://t.co/eyaYgUAVQo pic.twitter.com/v4FsS0NZNp
— Roche (@Roche) August 26, 2020
There are hundreds of #neurological disorders impacting millions of people – we all know someone who has been affected. We’re exploring innovative solutions and have more than 115 clinical trials ongoing. Find out more about Roche in #neuroscience: https://t.co/ysDtAwZ52M pic.twitter.com/rtGLrOnty8
— Roche (@Roche) August 26, 2020
#Didyouknow Zika virus infection is linked to brain defects in fetuses such as microcephaly as well as neurological complications in children and adults? #zika #diagnostics #valueofdiagnostics pic.twitter.com/nRZuIAa1xh
— Roche (@Roche) August 26, 2020
RT: We are proud to work together @PTCBio to bring life-changing innovations to patients #StrongerTogether #science #innovation https://t.co/84fFi6rbXj
— Roche (@Roche) August 10, 2020
Roche CEO Severin Schwan on #climate change: “I think the key is that we do something. Our philosophy is actions rather than words.” 👉 https://t.co/xLjPdV5oTO #EverGreener #RocheImpact #SharedPlanet #Environment pic.twitter.com/A1luHG5bml
— Roche (@Roche) August 1, 2020
When a patient gets better, they assume this to be the result of their treatment, especially if the experience is repeated over and over again. But is the assumption correct? What does constitute robust evidence, and why does it matter? Learn 👉 https://t.co/3QVKhOM8Fu #COVID19 pic.twitter.com/RJCorwsAwE
— Roche (@Roche) July 31, 2020
We are pleased to announce the FDA approval of a companion diagnostic test to help identify breast cancer patients eligible for targeted therapy: https://t.co/2Rd3ZBYbZH#Media $ROG $RHHBY #personalisedhealthcare pic.twitter.com/ATRsU29Eg3
— Roche (@Roche) July 29, 2020
We’re proud to be partnering with @TheADDF in #Alzheimers disease #TransformingLives #science #innovation https://t.co/74Qm0UcCTj
— Roche (@Roche) July 28, 2020
It was great to have members of our Alzheimer’s disease team sit down with @AlzDisInt at the start of the year. Watch the video to find out more 👇🏽 #TransformingLives #science #health #innovation https://t.co/rOXEoy9hRE
— Roche (@Roche) July 24, 2020
Neovascular or “wet” age-related #MacularDegeneration is the leading cause of #VisionLoss among people over the age of 60 and can severely impact everyday life for people living with the condition. Learn more here: https://t.co/ofNKivRRVD #EyeHealth pic.twitter.com/ITMfJI0Emx
— Roche (@Roche) July 24, 2020
We are excited to work together with @jnanatx to discover and develop novel medicines for difficult to drug targets in immunology and neurology. #StrongerTogether #Partnerships https://t.co/dn6RGmNKW2
— Roche (@Roche) July 21, 2020
Digitalisation opens up new opportunities to improve treatment decision-making in #cancercare. https://t.co/rHqxrxA60D
— Roche (@Roche) July 21, 2020
The potential of real world #data to improve #healthcare is increasingly recognised. This brings about a lot of important questions; listen in on the discussion. https://t.co/QG3kxmHXjp
— Roche (@Roche) July 20, 2020
RT: This partnership with @RED not only offers an opportunity to encourage more widespread #HIV diagnostic testing but also supports the @UNAIDS goal of an AIDS-free generation by 2030. https://t.co/RUU85DFaPp
— Roche (@Roche) July 15, 2020
#Digitalisation of medical practice has accelerated over the past months. Clinical decision support has shown to help navigate the complexity of decision making also virtually. https://t.co/wqpswWZo73 #oncology pic.twitter.com/L98NrSPEBn
— Roche (@Roche) July 15, 2020
We are proud to announce our second partnership with @BlueprintMed. https://t.co/9fziOjlr3E
— Roche (@Roche) July 14, 2020
Today we announce the tenth Breakthrough Therapy Designation for our #haematology medicines since 2013, as our novel bispecific #immunotherapy is granted the designation from the FDA for people with relapsed or refractory follicular #lymphoma. https://t.co/gL62WfHyi5 $RHHBY $ROG pic.twitter.com/7TDWIiITVm
— Roche (@Roche) July 14, 2020
We’re presenting new safety data from our phase IIIb #hemophilia A study at #ISTH2020. Learn more here: https://t.co/mYyuOdg9Gk $RHHBY $ROG pic.twitter.com/sO4Tl3mrb6
— Roche (@Roche) July 13, 2020
#Tumours are very diverse and there can be many new therapy targets hiding in them. That’s why homogenisation of samples can help receive more accurate #DNA sequencing results and improve personalised #patientcare. Curious how we do this? https://t.co/zVLQupH6GX #cancer pic.twitter.com/xkvCPbhgXN
— Roche (@Roche) July 3, 2020
#Cancer diagnosis is always challenging. How can we help make sure that patients get the best treatment? Learn how a simple kitchen blender is providing new insights into sampling methods and could potentially give hope to many patients. https://t.co/m3Vro7hq86 pic.twitter.com/4ctmDWzJFs
— Roche (@Roche) July 2, 2020
High-volume molecular diagnostic testing remains the backbone of the country’s COVID-19 testing response, but it cannot be the only option. Learn how other testing options play an important role:
Learn more: https://t.co/HbVHxuGk6c#Coronavirus #InThisTogether #StrongerTogether pic.twitter.com/EgdhLokP1j— Roche Diagnostics USA (@RocheDiaUSA) September 1, 2020
When and how can real-world data support development and approval of in vitro diagnostics? The @MDIConline, working alongside the @FDA, weighs in with a much-anticipated framework. Learn more: https://t.co/wBGZ1gkaXJ
— Roche Diagnostics USA (@RocheDiaUSA) August 24, 2020
This investment complements the development of Roche’s Nanopore technology, a next-generation #sequencing technology. #DNAsequencing #NGS https://t.co/K7FIyqi3yZ
— Roche Sequencing (@RocheSequencing) May 22, 2020
Learn how our newly launched #TargetEnrichment portfolio will increase #sequencing efficiency and, along with our library prep solution, reduce hands-on and turn-around time. https://t.co/nHLQIFWdHy #NGS pic.twitter.com/OUMONtiZ8S
— Roche Sequencing (@RocheSequencing) May 12, 2020
Thank you @SELFmagazine for the Adapalene Gel feature! "If pimples plague you, this topical treatment may be the answer. Reviewers love how this fragrance-free gel sank into skin superfast and worked overtime to clear up pimples."https://t.co/4fTy6U7DCG
— La Roche-Posay USA (@LaRochePosayUSA) July 12, 2020
Thank you @skincare for the feature. Acneic skin? Are toners part of your routine? Our Effaclar Astringent Toner, with its micro-exfoliating lipo-hydroxy acid, works to gently exfoliate and refine skin texture by unblocking and tightening large pores. https://t.co/R3kJMn4eDA
— La Roche-Posay USA (@LaRochePosayUSA) May 13, 2020